0000904454-14-000729.txt : 20141105
0000904454-14-000729.hdr.sgml : 20141105
20141105190752
ACCESSION NUMBER: 0000904454-14-000729
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141105
FILED AS OF DATE: 20141105
DATE AS OF CHANGE: 20141105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEVRO CORP
CENTRAL INDEX KEY: 0001444380
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4040 CAMPBELL AVENUE
STREET 2: SUITE 210
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-251-0005
MAIL ADDRESS:
STREET 1: 4040 CAMPBELL AVENUE
STREET 2: SUITE 210
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL
CENTRAL INDEX KEY: 0000924020
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36715
FILM NUMBER: 141198326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1212
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36715
FILM NUMBER: 141198327
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2014-11-05
0
0001444380
NEVRO CORP
NVRO
0000200406
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
0
0
1
0
0000924020
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
0
0
1
0
Series B Convertible Preferred Stock
Common Stock
2790178
I
By Johnson & Johnson Development Corporation
Series C Convertible Preferred Stock
Common Stock
246827
I
By Johnson & Johnson Development Corporation
The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person.
The shares of Preferred Stock are immediately convertible and have no expiration date. Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock will automatically convert into Common Stock, on a 1-to-1 basis, for no additional consideration.
Douglas Chia, Secretary of Johnson & Johnson
2014-11-05
Steven M. Rosenberg, Secretary of Johnson & Johnson Development Corporation
2014-11-05